Why is QMS Medical falling/rising?

As of 24-Sep, QMS Medical Allied Services Ltd is currently priced at 99.90, reflecting an increase of 1.05 or 1.06%. The stock has shown a mixed performance recently, with a decline of 6.64% over the past week, while it has risen by 18.72% over the past month. Today's price summary indicates that the stock is performing in line with its sector, although it is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, but lower than its 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume falling by 38.24% against the 5-day average. Despite a year-to-date decline of 11.94%, the company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 30.17%, and a PEG ratio of 1.7 suggests attractive valuation compared to peers.
In the broader market context, the stock has underperformed relative to the benchmark, with a one-year return of -23.51% compared to the Sensex's decline of only -3.41%. This underperformance is notable given that the overall market (BSE500) has generated negative returns of -5.32% in the last year. While the stock's recent price increase may reflect some positive sentiment due to its operating profit growth and attractive valuation, the significant drop in investor participation and the flat results reported in June 2025 indicate ongoing challenges. The stock's liquidity remains adequate for trading, but the overall trend suggests cautious investor sentiment amidst its historical performance.